AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 53(1), 1995, pp. 61-62
Copyright © 1995 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fallon, P. G.
Right arrow Articles by Doenhoff, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fallon, P. G.
Right arrow Articles by Doenhoff, M. J.

Short Report: Diminished Susceptibility to Praziquantel in a Senegal Isolate of Schistosoma mansoni

P. G. Fallon, R. F. Sturrock, A. Capron, M. Niang AND M. J. Doenhoff
School of Biological Sciences, University of Wales, Bangor, Gwynedd, United Kingdom; Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, London, United Kingdom; Centre d'Immunologie et de Biologie Parasitaire, Institut Pasteur, Lille, France; Service Regional de St. Louis, St. Louis, Senegal

There is a recent report of low efficacy of praziquantel (PZQ) treatment of human schistosomiasis in a new Schistosoma mansoni focus in northern Senegal. Biomphalaria pfeifferi snails with patent infections were collected from the area of the focus and transported to the United Kingdom. Groups of mice were infected with cercariae from this Senegalese isolate, or with laboratory-maintained Kenyan or Puerto Rican isolates. In two separate experiments, PZQ was less effective against the parasite from Senegal than against the two other geographic isolates. The reduced susceptibility of S. mansoni to PZQ in infected human populations has important implications for current schistosomiasis control programs.




This article has been cited by other articles:


Home page
Br Med BullHome page
A. Capron, M. Capron, and G. Riveau
Vaccine development against schistosomiasis from concepts to clinical trials
Br. Med. Bull., July 1, 2002; 62(1): 139 - 148.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society of Tropical Medicine and Hygiene.